Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Genomics In Cancer Care Market, by Application
1.4.2 Europe Genomics In Cancer Care Market, by Product
1.4.3 Europe Genomics In Cancer Care Market, by Technology
1.4.4 Europe Genomics In Cancer Care Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Mergers and Acquisitions: 2021, Jan – 2023, Jan) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. Europe Genomics In Cancer Care Market by Application
5.1 Europe Diagnostics Market by Country
5.2 Europe Personalized Medicine Market by Country
5.3 Europe Drug Discovery & Development Market by Country
5.4 Europe Research Market by Country
Chapter 6. Europe Genomics In Cancer Care Market by Product
6.1 Europe Instruments Market by Country
6.2 Europe Consumables Market by Country
6.3 Europe Services Market by Country
Chapter 7. Europe Genomics In Cancer Care Market by Technology
7.1 Europe PCR Market by Country
7.2 Europe Genome Sequencing Market by Country
7.3 Europe Microarrays Market by Country
7.4 Europe Nuclei Acid Extraction & Purification Market by Country
7.5 Europe Others Market by Country
Chapter 8. Europe Genomics In Cancer Care Market by Country
8.1 Germany Genomics In Cancer Care Market
8.1.1 Germany Genomics In Cancer Care Market by Application
8.1.2 Germany Genomics In Cancer Care Market by Product
8.1.3 Germany Genomics In Cancer Care Market by Technology
8.2 UK Genomics In Cancer Care Market
8.2.1 UK Genomics In Cancer Care Market by Application
8.2.2 UK Genomics In Cancer Care Market by Product
8.2.3 UK Genomics In Cancer Care Market by Technology
8.3 France Genomics In Cancer Care Market
8.3.1 France Genomics In Cancer Care Market by Application
8.3.2 France Genomics In Cancer Care Market by Product
8.3.3 France Genomics In Cancer Care Market by Technology
8.4 Russia Genomics In Cancer Care Market
8.4.1 Russia Genomics In Cancer Care Market by Application
8.4.2 Russia Genomics In Cancer Care Market by Product
8.4.3 Russia Genomics In Cancer Care Market by Technology
8.5 Spain Genomics In Cancer Care Market
8.5.1 Spain Genomics In Cancer Care Market by Application
8.5.2 Spain Genomics In Cancer Care Market by Product
8.5.3 Spain Genomics In Cancer Care Market by Technology
8.6 Italy Genomics In Cancer Care Market
8.6.1 Italy Genomics In Cancer Care Market by Application
8.6.2 Italy Genomics In Cancer Care Market by Product
8.6.3 Italy Genomics In Cancer Care Market by Technology
8.7 Rest of Europe Genomics In Cancer Care Market
8.7.1 Rest of Europe Genomics In Cancer Care Market by Application
8.7.2 Rest of Europe Genomics In Cancer Care Market by Product
8.7.3 Rest of Europe Genomics In Cancer Care Market by Technology
Chapter 9. Company Profiles
9.1 Agilent Technologies, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.6 SWOT Analysis
9.3 Danaher Corporation (Beckman Coulter, Inc.)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.6 SWOT Analysis
9.4 Abbott Laboratories
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 SWOT Analysis
9.5 Bio-Rad laboratories, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.5.6 SWOT Analysis
9.6 GE HealthCare Technologies, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.6 SWOT Analysis
9.7 Quest Diagnostics Incorporated
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental Analysis
9.7.4 SWOT Analysis
9.8 Revvity, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Acquisition and Mergers:
9.8.6 SWOT Analysis
9.9 Eurofins Scientific SE
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 SWOT Analysis
9.10. Hologic, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Acquisition and Mergers:
9.10.6 SWOT Analysis
Unique Offerings 